X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (42) 42
index medicus (34) 34
oncology (30) 30
female (25) 25
male (25) 25
middle aged (24) 24
aged (21) 21
radiotherapy (18) 18
adult (16) 16
cancer (12) 12
aged, 80 and over (11) 11
hematology, oncology and palliative medicine (10) 10
radiology, nuclear medicine & medical imaging (10) 10
survival (10) 10
treatment outcome (9) 9
glioblastoma (8) 8
radiation-therapy (8) 8
tumors (8) 8
care and treatment (7) 7
chemotherapy (7) 7
disease-free survival (7) 7
lung cancer (7) 7
lung neoplasms - radiotherapy (7) 7
brain neoplasms - drug therapy (6) 6
dacarbazine - analogs & derivatives (6) 6
glioblastoma - drug therapy (6) 6
inflammation (6) 6
kaplan-meier estimate (6) 6
medical research (6) 6
respiratory system (6) 6
survival analysis (6) 6
young adult (6) 6
analysis (5) 5
animals (5) 5
brain cancer (5) 5
brain tumors (5) 5
clinical neurology (5) 5
diagnosis (5) 5
glioblastoma multiforme (5) 5
malignant glioma (5) 5
proportional hazards models (5) 5
radiation therapy (5) 5
radiotherapy dosage (5) 5
research (5) 5
retrospective studies (5) 5
risk factors (5) 5
temozolomide (5) 5
abridged index medicus (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
carcinoma (4) 4
carcinoma, non-small-cell lung - radiotherapy (4) 4
conformal radiotherapy (4) 4
dacarbazine - therapeutic use (4) 4
dna methylation (4) 4
glioma (4) 4
gliomas (4) 4
health aspects (4) 4
irradiation (4) 4
lung neoplasms - mortality (4) 4
medicine, experimental (4) 4
newly-diagnosed glioblastoma (4) 4
patients (4) 4
population (4) 4
prospective studies (4) 4
radiation (4) 4
studies (4) 4
surgery (4) 4
surveys and questionnaires (4) 4
trial (4) 4
adjuvant temozolomide (3) 3
adolescent (3) 3
antineoplastic agents, alkylating - therapeutic use (3) 3
article (3) 3
brain (3) 3
brain neoplasms - genetics (3) 3
brain neoplasms - mortality (3) 3
brain neoplasms - psychology (3) 3
brain neoplasms - radiotherapy (3) 3
carcinoma, non-small-cell lung - pathology (3) 3
chi-square distribution (3) 3
clinical trials (3) 3
cohort studies (3) 3
dacarbazine - administration & dosage (3) 3
dacarbazine - adverse effects (3) 3
delineation (3) 3
drug administration schedule (3) 3
end results database (3) 3
epidemiology (3) 3
expression (3) 3
follow-up studies (3) 3
glioblastoma - genetics (3) 3
glioblastoma - mortality (3) 3
glioblastoma - pathology (3) 3
high-grade glioma (3) 3
impact (3) 3
integrins (3) 3
lung neoplasms - diagnostic imaging (3) 3
lung neoplasms - drug therapy (3) 3
lung neoplasms - pathology (3) 3
lung neoplasms - therapy (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1100 - 1108
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2010, Volume 28, Issue 30, pp. 4601 - 4608
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 05/2018, Volume 138, Issue 1, pp. 163 - 171
Journal Article
by Weller, Michael and Butowski, Nicholas and Tran, David D and Recht, Lawrence and Recht, Lawrence D and Lim, Michael and Hirte, Hal and Ashby, Lynn and Mechtler, Laszlo and Goldlust, Samuel and Goldlust, Samuel A and Iwamoto, Fabio and Drappatz, Jan and O'Rourke, James and O'Rourke, Donald M and Wong, Mark and Hamilton, Mark G and Hamilton, Mark and Finocchiaro, Gaetano and Perry, James and Wick, Wolfgang and Green, Jennifer and He, Yi and Turner, Christopher D and Yellin, Michael J and Keler, Tibor and Davis, Thomas A and Stupp, Roger and Sampson, John H and Campian, Jian and Becker, Kevin and Barnett, Gene and Nicholas, Garth and Desjardins, Annick and Benkers, Tara and Wagle, Naveed and Groves, Morris and Kesari, Santosh and Horvath, Zsolt and Merrell, Ryan and Curry, Richard and Schuster, David and Mrugala, Maciej and Jensen, Randy and Trusheim, John and Lesser, Glenn and Belanger, Karl and Sloan, Andrew and Purow, Benjamin and Fink, Karen and Raizer, Jeffrey and Schulder, Michael and Nair, Suresh and Peak, Scott and Brandes, Alba and Mohile, Nimish and Landolfi, Joseph and Olson, Jon and Jennens, Ross and DeSouza, Paul and Robinson, Bridget and Crittenden, Marka and Shih, Kent and Flowers, Alexandra and Ong, Shirley and Connelly, Jennifer and Hadjipanayis, Costas and Giglio, Pierre and Mott, Frank and Mathieu, David and Lessard, Nathalie and Sepulveda, Sanchez Juan and Lövey, József and Wheeler, Helen and Inglis, Po-Ling and Hardie, Claire and Bota, Daniela and Lesniak, Maciej and Portnow, Jana and Frankel, Bruce and Junck, Larry and Thompson, Reid and Berk, Lawrence and McGhie, John and Macdonald, David and Saran, Frank and Soffietti, Riccardo and Blumenthal, Deborah and André de, Sá Barreto Costa Marcos and Nowak, Anna and Singhal, Nimit and Hottinger, Andreas and Schmid, Andrea and Srkalovic, Gordan and Baskin, David and Fadul, Camilo and Nabors, Louis and LaRocca, Renato and Villano, John and Paleologos, Nina and ... and ACT IV Trial Investigators and ACT IV trial investigators
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1373 - 1385
Rindopepimut (also known as CDX-110), a vaccine targeting the deletion mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet... 
GLIOMAS | ONCOLOGY | RECURSIVE PARTITIONING ANALYSIS | GROWTH-FACTOR | RADIOTHERAPY | CANCER | PEPTIDE | ADJUVANT TEMOZOLOMIDE | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Brain Neoplasms - pathology | ErbB Receptors - genetics | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Dose-Response Relationship, Drug | Young Adult | Glioblastoma - genetics | Time Factors | Dacarbazine - analogs & derivatives | Adult | Female | Vaccines, Subunit - adverse effects | Brain Neoplasms - mortality | Dacarbazine - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Cancer Vaccines - adverse effects | Treatment Outcome | Brain Neoplasms - drug therapy | Disease-Free Survival | Internationality | Vaccines, Subunit - administration & dosage | Glioblastoma - pathology | Survival Analysis | Aged | Temozolomide | Glioblastoma - drug therapy | Glioblastoma - mortality | Antimitotic agents | Clinical trials | Care and treatment | Product development | Antineoplastic agents | Glioblastoma multiforme | Analysis
Journal Article
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, ISSN 1469-493X, 2019, Volume 8, Issue 8, p. CD013047
Background Gliomas are brain tumours arising from glial cells with an annual incidence of 4 to 11 people per 100,000. In this review we focus on gliomas with... 
PHASE-III TRIAL | MEDICINE, GENERAL & INTERNAL | ANAPLASTIC OLIGODENDROGLIOMA | EUROPEAN ORGANIZATION | LOW-GRADE GLIOMA | RANDOMIZED-TRIAL | QUALITY-OF-LIFE | COGNITIVE FUNCTION | MEDICAL-RESEARCH-COUNCIL | RADIATION-THERAPY | BRAIN-TUMORS
Journal Article